Taubert Jennifer L
SEC CIK 1745938 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | EVP, WWC. Innovative Medicine | 209.5K | — | $36.87M | 27 | 2022-02-14 | 2026-08-17 |
Most active insiders at JNJ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duato Joaquin | CEO, COB, Dir | — | $66.84M |
| 2 | Wolk Joseph J | EVP, CFO | — | $21.77M |
| 3 | REED JOHN C | EVP, Innovative Medicine, R, D | — | $17.29M |
| 4 | Swanson James D. | EVP, CIO | — | $15.11M |
| 5 | Schmid Timothy | EVP, WW COB, MedTech | — | $15.08M |
| 6 | Broadhurst Vanessa | EVP, Gbl Corp Affairs | — | $7.30M |
| 7 | Forminard Elizabeth | EVP, CLO | — | $4.09M |
| 8 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | — | $3.95M |
| 9 | Wengel Kathryn E | EVP, Chief TO, Risk Off | — | $2.41M |
| 10 | Decker Robert J | VP Corp. Ctrl | — | $1.01M |
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-18 18:31 | 2026-08-17 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $115.67 | +15.0K | 209.5K | +8% | +$1.74M |
| D | 2026-08-18 18:31 | 2026-08-17 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | S - Sale+OE | $263.36 | -15.0K | 194.5K | -7% | -$3.95M |
| DM | 2026-02-18 21:11 | 2026-02-13+ | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $0.00 | +32.2K | 195.4K | +20% | $0 |
| DM | 2026-02-18 21:11 | 2026-02-13+ | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F - Tax | $244.43 | -15.7K | 194.5K | -7% | -$3.84M |
| D | 2025-09-05 18:00 | 2025-09-04 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $101.87 | +56.5K | 234.5K | +32% | +$5.75M |
| D | 2025-09-05 18:00 | 2025-09-04 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | S - Sale+OE | $177.81 | -56.5K | 178.0K | -24% | -$10.04M |
| DM | 2025-02-18 21:08 | 2025-02-13+ | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $0.00 | +22.4K | 185.9K | +14% | $0 |
| DM | 2025-02-18 21:08 | 2025-02-14+ | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F - Tax | $156.62 | -10.3K | 178.0K | -5% | -$1.62M |
| D | 2025-02-11 19:41 | 2025-02-07 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $100.06 | +58.5K | 213.4K | +38% | +$5.85M |
| D | 2025-02-11 19:41 | 2025-02-07 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F - Tax | $153.12 | -47.4K | 165.9K | -22% | -$7.26M |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $0.00 | +1,302 | 155.5K | +0.8% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F - Tax | $157.85 | -666 | 154.9K | -0.4% | -$105.1K |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $0.00 | +26.2K | 167.6K | +19% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F - Tax | $157.40 | -13.4K | 154.2K | -8% | -$2.11M |
| DM | 2024-02-12 19:25 | 2024-02-08+ | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $85.08 | +63.1K | 200.8K | +46% | +$5.37M |
| D | 2024-02-12 19:25 | 2024-02-08 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $156.33 | -1,913 | 141.4K | -1% | -$299.1K |
| D | 2024-02-12 19:25 | 2024-02-09 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | S - Sale+OE | $156.27 | -59.4K | 141.4K | -30% | -$9.28M |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | A - Grant | $0.00 | +21.4K | 150.2K | +17% | $0 |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $162.01 | -10.6K | 139.6K | -7% | -$1.71M |
| D | 2023-02-14 16:36 | 2023-02-10 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $0.00 | +3,570 | 130.0K | +3% | $0 |
| D | 2023-02-14 16:36 | 2023-02-10 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $162.08 | -1,289 | 128.7K | -1.0% | -$208.9K |
| D | 2022-11-23 16:44 | 2022-11-22 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $72.54 | +76.9K | 203.4K | +61% | +$5.58M |
| D | 2022-11-23 16:44 | 2022-11-22 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | S - Sale+OE | $176.78 | -76.9K | 126.5K | -38% | -$13.60M |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $0.00 | +18.1K | 135.3K | +15% | $0 |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $165.89 | -8,841 | 126.5K | -7% | -$1.47M |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $0.00 | +3,297 | 118.4K | +3% | $0 |
| D | 2022-02-15 20:02 | 2022-02-14 | JNJ | Johnson & Johnson | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $168.85 | -1,190 | 117.2K | -1% | -$200.9K |
Purchase Sale Sale after option exercise All abbreviations